Association of dipeptidyl peptidase-4 inhibitor use and risk of pancreatic cancer in individuals with diabetes in Japan.

Sodai KubotaTakuya HaraguchiHitoshi KuwataYusuke Seino Kenta MurotaniTakumi TajimaGen TerashimaMakiko KanekoYoshihiro Takahashi Ken Takao Takehiro KatoKenichiro ShideSaeko ImaiAtsushi Suzuki Yasuo TerauchiYuichiro YamadaYutaka SeinoDaisuke Yabe

Published in: Journal of diabetes investigation (2022)

This database study shows that there is not a significant PC risk due to DPP-4i treatment in individuals with diabetes in Japan, but larger studies with longer follow up are required to confirm these findings.

Keyphrases

type diabetes
cardiovascular disease
glycemic control
combination therapy
adipose tissue